Aeras Email Format

BiotechnologyMaryland, United States51-200 Employees

Aeras is a nonprofit biotechnology organization focused on advancing vaccines against tuberculosis. It works with partners across Africa, Asia, North America, and Europe to support clinical evaluation of six experimental TB vaccines and to maintain a broader portfolio of earlier-stage candidates. The group operates from Rockville, Maryland, and has bases in Cape Town and Beijing to support its international program. The work aims to address global TB vaccine needs through collaborative research and development.

In the biotechnology research landscape, Aeras positions itself as a nonprofit conducting translational vaccine research with an international collaboration model and a focused TB vaccine pipeline. In February 2022, the organization sold assets to the International AIDS Vaccine Initiative, and IAVI subsequently acquired the clinical assets.

Sign up for free to view info

Company overview Employee directory